...
机译:GATA3控制的核心驱逐推动T细胞发育和白血病中的MYC增强剂活性
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Rutgers State Univ Rutgers Canc Inst New Jersey New Brunswick NJ USA;
Columbia Univ Dept Syst Biol New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Eunice Kennedy Shriver Natl Inst Child Hlth &
Hum Div Dev Biol NIH Bethesda MD USA;
Ludwig Inst Canc Res La Jolla CA USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
Princess Maxima Ctr Pediat Oncol Dept Pediat Oncol Hematol Utrecht Netherlands;
Princess Maxima Ctr Pediat Oncol Dept Pediat Oncol Hematol Utrecht Netherlands;
Columbia Univ Dept Syst Biol New York NY USA;
Columbia Univ Inst Canc Genet New York NY USA;
机译:GATA3控制的核心驱逐推动T细胞发育和白血病中的MYC增强剂活性
机译:TLX1和Stat5的合作增强剂激活在NUP214-ABL1 / TLX1阳性T细胞急性淋巴细胞白血病中的白血病发育
机译:在T细胞急性淋巴细胞白血病中致癌物质和MYC增强剂活性需要RUNX1
机译:用于T细胞急性淋巴细胞白血病衍生细胞的较高生长抑制性的化合物的产生
机译:在T细胞急性淋巴细胞白血病中针对毛发和Split 1(HES1)转录增强子的治疗靶向
机译:RUNX1是T细胞急性淋巴细胞白血病致癌Myb和Myc增强子活性所必需的
机译:GATA3控制的核心驱逐推动T细胞发育和白血病中的MYC增强剂活性